DNA METHYLATION AS A BIOMARKER OF TOCILIZUMAB RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS

被引：0
|
作者：
Nair, N. [1 ]
Plant, D. [1 ]
Isaacs, J. [2 ,3 ]
Morgan, A. [4 ,5 ]
Hyrich, K. [6 ,7 ]
Barton, A. [1 ,6 ]
Wilson, A. G. [8 ]
机构：
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Genet & Genom Versus Arthrit, Manchester, Lancs, England
[2] Newcastle Univ, Newcastle Upon Tyne, England
[3] Musculoskeletal Directorate, Translat & Clin Res Inst, Newcastle Upon Tyne, England
[4] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, England
[5] Leeds Teaching Hosp Teaching Trust, NIHR Leeds BRC, Leeds, England
[6] Manchester Univ NHS Fdn Trust, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, England
[7] Univ Manchester, Manchester Acad Hlth Sci Ctr, Versus Arthrit Ctr Epidemiol, Manchester, England
[8] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.3102
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0011
引用
收藏
页码：1141 / 1141
页数：1
相关论文
共 50 条
  • [41] DIFFERENTIAL METHYLATION RELATED TO RESPONSE TO ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Webster, A.
    Plant, D.
    Eyre, S.
    Flynn, E.
    Martin, P.
    Wilson, G.
    Morgan, A. W.
    Isaacs, J.
    Worthington, J.
    Barton, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 67 - 67
  • [42] Associations of genetic polymorphisms with clinical response to tocilizumab in Chinese rheumatoid arthritis patients
    Qin, Wen
    Wang, Meng-Qiao
    Wang, Ting-Hui
    Xiao, Dong-Mei
    Wu, Xiu-Di
    Cen, Han
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 146
  • [43] Early Neutropenia Is Associated with Clinical Response in Patients Receiving Tocilizumab in Rheumatoid Arthritis
    Kostine, Marie
    Barnetche, Thomas
    Ardouin, Elodie
    Joly, Marlene
    Rabois, Emilie
    Glace, Baptiste, Sr.
    Nigon, Delphine
    Schaeverbeke, Thierry
    Richez, Christophe
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S558 - S559
  • [44] Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
    Mori, Shunsuke
    Ueki, Yukitaka
    Hirakata, Naoyuki
    Oribe, Motohiro
    Hidaka, Toshihiko
    Oishi, Kazunori
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (12) : 2006 - 2010
  • [45] TOCILIZUMAB IMPROVES SYSTEMIC SYMPTOMS OF RHEUMATOID ARTHRITIS IN PATIENTS WITH AN INADEQUATE RESPONSE TO DMARDs
    Bonfiglioli, R.
    Smolen, J.
    Kissel, K.
    Cocco, Maldonado J.
    Ramos-Remus, C.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S32 - S32
  • [46] Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis
    Shimamoto, Keiko
    Ito, Tomoki
    Ozaki, Yoshio
    Amuro, Hideki
    Tanaka, Akihiro
    Nishizawa, Tohru
    Son, Yonsu
    Inaba, Muneo
    Nomura, Shosaku
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (07) : 1074 - 1081
  • [47] IS EARLY NEUTROPENIA ASSOCIATED WITH CLINICAL RESPONSE IN PATIENTS RECEIVING TOCILIZUMAB IN RHEUMATOID ARTHRITIS?
    Kostine, M.
    Barnetche, T.
    Ardouin, E.
    Joly, M.
    Rabois, E.
    Glace, B.
    Schaeverbeke, T.
    Richez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 377 - 377
  • [48] Tocilizumab for rheumatoid arthritis
    Singh, Jasvinder A.
    Beg, Saba
    Lopez-Olivo, Maria Angeles
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (07):
  • [49] Tocilizumab in rheumatoid arthritis
    Rueda Gotor, Javier
    Blanco Alonso, Ricardo
    REUMATOLOGIA CLINICA, 2011, 6 : S29 - S32
  • [50] ADAMTS5 Is a Biomarker For The Efficacy Prediction Of Tocilizumab In Rheumatoid Arthritis
    Tsuzaka, Kensei
    Takao, Masako
    Nishida, Jiro
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S962 - S963
12345